About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Texas | 857 Studies

Clinical Trials Prostate CancerTexas

Prostate Cancer Clinical Trials in Texas

Find 857 clinical trials for prostate cancer near Texas. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Texas

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 581-600 of 857 trials

RecruitingA Study of MGC026 in Participants With Advanced Solid TumorsThe study is designed to understand the safety, tolerability, pharmacokinetics, immunogenicity, and preliminary antitumor activity of MGC026 in participants with relapsed or…NCT06242470·Los Angeles, California and 11 others RecruitingA Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)This is a first-in-human, Phase 1/2, open-label, dose escalation, dose expansion and combination study designed to evaluate the safety, tolerability, pharmacokinetics…NCT05652686·Duarte, California and 14 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

Active not recruitingA Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant Solid TumorsThe purpose of this study is to characterize the safety and tolerability of ALTA2618 in adults with AKT1 E17K-mutant advanced solid tumors.NCT06533059·La Jolla, California and 30 others

CompletedInterstitial Brachytherapy With or Without External-Beam Radiation Therapy in Treating Patients With Prostate CancerRATIONALE: Radiation therapy uses high-energy x-rays and other sources to damage tumor cells.NCT00063882·Phoenix, Arizona and 169 others

CompletedA Study of Rucaparib Versus Physician's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene DeficiencyThe purpose of this study is to determine how participants with metastatic castration-resistant prostate cancer, and evidence of a homologous recombination gene deficiency…NCT02975934·Birmingham, Alabama and 149 others

TerminatedCirculating Tumor Cells in Prostate Cancer PatientsThe purpose of this study is to determine if a non-invasive cancer treatment, high-dose stereotactic body radiotherapy (SBRT), is associated with changes in circulating tumor…NCT01414712·Dallas, Texas

CompletedEvaluating Symptom Management Educational Materials for Patients With Prostate CancerRATIONALE: Collecting feedback from patients with prostate cancer may help doctors develop better symptom management educational materials for patients.NCT00769431·Houston, Texas and 1 other

RecruitingThe MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac StudyThe Multi-OutcoMe EvaluatioN of radiation Therapy Using the Unity MR-Linac Study (MOMENTUM) is a multi-institutional, international registry facilitating evidenced based…NCT04075305·Pittsburgh, Pennsylvania and 17 others

CompletedCHESS: Human and Computer Mentors for Prostate Cancer PatientsThe aims include: 1. To measure the effect of the three study conditions on Quality of Life (QOL).NCT00516256·Hartford, Connecticut and 2 others

RecruitingCryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME TrialThis trial compares cryoablation combined with stereotactic body radiation therapy to stereotactic body radiation therapy alone to see how well they work in treating patients with…NCT04693377·Houston, Texas

CompletedExtension Study Investigating the Long-Term Safety of Degarelix One-Month Depots in Patients With Prostate CancerThis was an extension study for the study FE200486 CS14 (NCT00116779).NCT00117286·Homewood, Alabama and 21 others

CompletedS0032, Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Androgens can stimulate the growth of prostate cancer cells.NCT00028769·Mobile, Alabama and 90 others

Active not recruitingA Study to Assess Adverse Events, and How Intravenously (IV) Infused ABBV-969 Moves Through the Bodies of Adult Participants With Metastatic Castration-Resistant Prostate CancerProstate cancer has the second highest incidence rate and is the fifth leading cause of cancer-related deaths among men worldwide.NCT06318273·Duarte, California and 25 others

Active not recruitingA Multi-Center Trial of Androgen Suppression With Abiraterone Acetate, Leuprolide, PARP Inhibition and Stereotactic Body Radiotherapy in Prostate CancerThe purpose of this study is to establish the maximum tolerable dose of niraparib when combined with prostate stereotactic body radiotherapy (SBRT), abiraterone, leuprolide, and…NCT04194554·Ann Arbor, Michigan and 5 others

CompletedCPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced CancersThis is a Phase 1/1b open-label, dose escalation and dose expansion study of CPI-006, a humanized monoclonal antibody (mAb) targeting the CD73 cell-surface ectonucleotidase in…NCT03454451·Tucson, Arizona and 26 others

Active not recruitingLifestyle Intervention for the Reduction of Prostate Cancer Disparities Among African AmericansThis trial studies how well a lifestyle intervention works in reducing prostate cancer disparities among African American prostate cancer patients and their spouses or romantic…NCT04215029·Houston, Texas

CompletedA Safety Trial of MVA-BN®-PRO in Men With Androgen-Insensitive Prostate CancerBNIT-PR-001 is an open-label, multi-center, Phase I dosing evaluation trial of MVA-BN®-PRO in men with androgen-insensitive prostate cancer.NCT00629057·Homewood, Alabama and 6 others

CompletedA Comparative Study of Degarelix Three-month Depot in Three Different Dosing Regimens in Patients With Prostate CancerThe rationale of the study was to evaluate different degarelix dosing regimens for a three-month interval that was to produce and maintain castration in prostate cancer patients…NCT00116753·Homewood, Alabama and 55 others

UnknownClinical Study of the Sonablate® 500 to Treat Localized (T1c/T2a) Prostate CancerThis study will compare high intensity focused ultrasound to standard brachytherapy in the treatment of primary, organ confined prostate cancer.NCT00770822·Birmingham, Alabama and 5 others

CompletedA Study to Evaluate the Potential Increased Risk of Seizures Among Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated With EnzalutamideThe objective of this study was to evaluate the incidence of seizures and monitor the safety of enzalutamide treatment in participants with metastatic castration-resistant…NCT01977651·Anchorage, Alaska and 75 others

PreviousPage 30 of 43Next

Other Conditions in Texas

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma